![Joanne M. Conroy M.D. Chairperson's File 900x400 as of 2-26-24](/sites/default/files/2024-02/joanne-m-conroy-md-chairpersons-file-900x400-as-of-2-26-2024.jpg)
The share of U.S. overdose deaths involving buprenorphine did not increase after federal agencies allowed clinicians to prescribe the opioid use disorder treatment remotely, among other flexibilities during the COVID-19 public health emergency, according to a federal study reported in JAMA Network Open.